To overcome its off-target cytotoxicity and insolubility and for tumor-specific localization, we encapsulated 2c in PLGA (US-FDA-approved polymer) nanoparticles conjugated with aptamer (Apt-2cNP) that bind EpCAM. Here, EPCAM is linked to neoplasm.